flowchart TD
JAK["JAK<br/>Janus Kinase"]
IL6["IL-6<br/>Interleukin-6"]
CYTOKINES["Cytokines<br/>Inflammatory Signals"]
ERK["ERK<br/>Extracellular Signal<br/>Regulated Kinase"]
JAKSTAT["JAK-STAT<br/>Pathway"]
NFKB["NF-kappaB<br/>Pathway"]
MAPK["MAPK<br/>Pathway"]
STAT3["STAT3<br/>Signal Transducer"]
INFLAMMATION["Neuroinflammation<br/>Process"]
ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
ALZHEIMERS["Alzheimer's<br/>Disease"]
CANCER["Cancer<br/>Neoplastic Disease"]
AUTOIMMUNE["Autoimmune<br/>Disorders"]
THERAPEUTIC["Therapeutic<br/>Target"]
IL6 -->|"activates"| JAK
CYTOKINES -->|"inhibits"| JAK
ERK -->|"activates"| JAK
INFLAMMATION -->|"activates"| JAK
JAK -->|"activates"| JAKSTAT
JAK -->|"activates"| NFKB
JAK -->|"activates"| MAPK
JAKSTAT -->|"regulates"| STAT3
JAK -->|"regulates"| INFLAMMATION
JAK -->|"regulates"| ALS
JAK -->|"associated_with"| ALZHEIMERS
JAK -->|"activates"| CANCER
JAK -->|"therapeutic_target"| AUTOIMMUNE
JAK -->|"therapeutic_target"| THERAPEUTIC
style JAK fill:#006494,color:#e0e0e0
style JAKSTAT fill:#4a1a6b,color:#e0e0e0
style STAT3 fill:#4a1a6b,color:#e0e0e0
style NFKB fill:#4a1a6b,color:#e0e0e0
style MAPK fill:#4a1a6b,color:#e0e0e0
style INFLAMMATION fill:#ef5350,color:#0d0d1a
style ALS fill:#5d4400,color:#e0e0e0
style ALZHEIMERS fill:#5d4400,color:#e0e0e0
style CANCER fill:#ef5350,color:#0d0d1a
style THERAPEUTIC fill:#1b5e20,color:#e0e0e0
style AUTOIMMUNE fill:#6d3b00,color:#e0e0e0
Overview
...
JAK1 Protein — Janus Kinase 1
Pathway Diagram
Mermaid diagram (expand to render)
Overview
Jak1 Protein — Janus Kinase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Jak1 Protein — Janus Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
JAK1 is a non-receptor tyrosine kinase with a FERM domain for receptor binding, an SH2-like domain, a pseudokinase (JH2) domain with regulatory function, and a kinase (JH1) domain with catalytic activity. The JH2 domain acts as an autoinhibitory module, preventing constitutive activation. JAK1 associates with cytokine receptors through its FERM domain. Upon ligand binding and receptor dimerization, JAKs trans-activate and phosphorylate receptor tyrosine residues.
Normal Function in the Nervous System
In the CNS, JAK1 mediates signaling for multiple cytokines:
Type I and Type II interferon signaling in [microglia](/cell-types/microglia-neuroinflammation)
IL-6 family cytokine signaling in [astrocytes](/entities/astrocytes)
Jak1 Protein — Janus Kinase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Jak1 Protein — Janus Kinase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data